XML 69 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Detail) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue      
Commercial sale of products € 35,659 € 943  
Rendering of services 4,434 751 € 2,140
Sale of clinical supply 8,534 3,719 2,206
Licenses 2,547 2,365 2,607
Total revenue 51,174 7,778 6,953
Revenue (geographical)      
Total revenue 51,174 7,778 6,953
Goods or services transferred over time [member]      
Revenue      
Total revenue 4,434 751 2,140
Revenue (geographical)      
Total revenue 4,434 751 2,140
Goods or services transferred at point in time [member]      
Revenue      
Total revenue 46,740 7,027 4,813
Revenue (geographical)      
Total revenue 46,740 7,027 4,813
Commercial customers [Member]      
Revenue      
Total revenue 35,659 943  
Revenue (geographical)      
Total revenue 35,659 943  
Collaboration partners and license agreements [Member]      
Revenue      
Total revenue 15,515 6,835 6,953
Revenue (geographical)      
Total revenue 15,515 6,835 6,953
Europe [member]      
Revenue      
Total revenue 552    
Revenue (geographical)      
Total revenue 552    
North America [member]      
Revenue      
Total revenue 44,156 6,856 2,679
Revenue (geographical)      
Total revenue 44,156 6,856 2,679
China [member]      
Revenue      
Total revenue 6,466 922 4,274
Revenue (geographical)      
Total revenue € 6,466 € 922 € 4,274